New York, NY, April 03, 2019 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Neurostimulation Devices Market by Product (Deep Brain Stimulation Devices, Spinal Cord Stimulation Devices, Gastric Electric Stimulation Devices, Vagus Nerve Stimulation Devices, Sacral Nerve Stimulation Devices, and Others), by Application (Parkinson’s Disease, Epilepsy, Pain Management, Essential Tremor, Urinary and Fecal Incontinence, Alzheimer’s, Ischemia, and Others), and by End-User (Hospitals, Scientific Research Laboratories, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025”. According to the report, the global neurostimulation devices market was approximately USD 6,588 million in 2018 and is expected to generate around USD 15,404 million by 2025, at a CAGR of around 12.9% between 2019 and 2025.
New technologies are being developed and researches have been revealing more potential uses of this treatment. This, in turn, is fuelling the rising demand for safer and cost-effective treatment options. Moreover, the increasing prevalence of diseases that are treated with neurostimulation therapy is the major growth factor of the global neurostimulation devices market. In addition, the increasing number of FDA approvals for clinical trials in this area is also propelling the global neurostimulation devices market. However, the lack of well-trained professionals and non-measurable outcomes are affecting the growth of the neurostimulation devices market globally. Alternatively, the need to provide safe and improved care to patients suffering from neurological disorders and government support in emerging countries are expected to generate new market opportunities over the forecast time period.
Browse through 54 Tables & 35 Figures spread over 110 Pages and in-depth TOC on “Global Neurostimulation Devices Market: By Type, Size, Share, Trends, Companies, Growth, Industry Analysis and Forecast 2018–2025”.
Request Free Sample Report of Global Neurostimulation Devices Market Report @ https://www.zionmarketresearch.com/sample/neurostimulation-devices-market
The global neurostimulation devices market is segmented on the basis of product, application, and end-user. Based on product, the neurostimulation devices market is classified into deep brain stimulation devices, gastric electric stimulation devices, spinal cord stimulation devices, vagus nerve stimulation devices, sacral nerve stimulation devices, and others. Spinal cord stimulation devices dominated the market in 2018 and are likely to show the highest CAGR in the future. This can be attributed to its wide applications in pain management and high market penetration due to commercially available products. The use of deep brain stimulator devices for Tourette syndrome, Alzheimer’s, cluster headache, refractory epilepsy trigeminal neuralgia, and movement disorders by multiple sclerosis are awaiting FDA approval, which will boost the market growth for these devices globally.
On the basis of application, the market is segmented into epilepsy, Parkinson's disease, pain management, essential tremor, urinary and fecal incontinence, Alzheimer’s, ischemia, and others. The pain management segment dominated the market in 2018, due to the rising prevalence rate of chronic disorders and growing neurostimulation devices adoption for pain management owing to its high therapeutic value. Parkinson’s disease is also likely to grow notably in the future, owing to the growing geriatric population base and low availability of treatment options for this disease type. As per the WHO, depression is the leading cause of ill health globally. Estimates have suggested that more than 500 million individuals suffer from depression worldwide, with an increase of over 20% between 2005 and 2015.
Download Free Report PDF Brochure: https://www.zionmarketresearch.com/requestbrochure/neurostimulation-devices-market
Based on end-user, the market includes hospitals, scientific research laboratories, and others. The increasing prevalence of neurological diseases is fuelling the growth of the hospital segment globally.
North America and Europe held major shares of the global neurostimulation devices market in 2018. This can be attributed to the growing awareness regarding preventive care, increasing neurological diseases, such as epilepsy, migraine, Parkinson’s disease, and incontinence. Countries like Canada, UK, and France are likely to show noticeable growth in the future, owing to the emerging technologies in the neurostimulation devices market. Government and private organizations in these regions are frequently running awareness campaigns on neurological disorders and their associated health impediments.
Browse the full “Neurostimulation Devices Market by Product (Deep Brain Stimulation Devices, Spinal Cord Stimulation Devices, Gastric Electric Stimulation Devices, Vagus Nerve Stimulation Devices, Sacral Nerve Stimulation Devices, and Others), by Application (Parkinson’s Disease, Epilepsy, Pain Management, Essential Tremor, Urinary and Fecal Incontinence, Alzheimer’s, Ischemia, and Others), and by End-User (Hospitals, Scientific Research Laboratories, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025” Report at https://www.zionmarketresearch.com/report/neurostimulation-devices-market
Asia Pacific is likely to grow significantly in the neurostimulation devices market and register the highest CAGR over the estimated timeframe. The Asian neurostimulation devices market is majorly driven by China and India, as these countries provide investment opportunities for the neurostimulation devices manufacturers. Additionally, high economic growth is observed in these countries, owing to the presence of a vast patient pool. These countries have witnessed improving facilities in healthcare largely due to the expansion of both public and private sector companies that have been collaborating with multinational healthcare establishments to provide better treatment options, thus supporting this regional market.
The economically developing regions like Latin America and the Middle East and Africa are still behind the developed countries. However, these regions also have huge potential for growth in the global neurostimulation devices market and are likely to be the fastest growing regions, owing to the rapidly growing healthcare infrastructure and opportunities and funds provided by the government to the manufacturers to conduct research activities for improved patient care.
Inquire more about this report before purchase @ https://www.zionmarketresearch.com/inquiry/neurostimulation-devices-market
Some leading players of the global neurostimulation devices market include Boston Scientific Corporation, Medtronic Inc., Cyberonics Inc., NeuroPace Inc., St. Jude Medical Inc., and NeuroSigma, Inc.
Request customized copy of report @ https://www.zionmarketresearch.com/custom/3982
This report segments the global neurostimulation devices market into:
Global Neurostimulation Devices Market: Product Analysis
- Deep Brain Stimulation Devices
- Spinal Cord Stimulation Devices
- Gastric Electric Stimulation Devices
- Vagus Nerve Stimulation Devices
- Sacral Nerve Stimulation Devices
- Others
Global Neurostimulation Devices Market: Application Analysis
- Parkinson’s Disease
- Epilepsy
- Pain Management
- Essential Tremor
- Urinary and Fecal Incontinence
- Alzheimer’s
- Ischemia
- Others
Global Neurostimulation Devices Market: End-User Analysis
- Hospitals
- Scientific Research Laboratories
- Others
Global Neurostimulation Devices Market: Regional Analysis
- North America
- The U.S.
- Europe
- UK
- France
- Germany
- Asia Pacific
- China
- Japan
- India
- Latin America
- Brazil
- The Middle East and Africa
Related Reports:
- Allergy Diagnostics Market: https://www.zionmarketresearch.com/report/allergy-diagnostics-market
- Sinus Dilation Devices Market: https://www.zionmarketresearch.com/report/sinus-dilation-devices-market
- Surgical Retractors Market: https://www.zionmarketresearch.com/report/surgical-retractor-market
- Wearable Injectors Market: https://www.zionmarketresearch.com/report/wearable-injectors-market
- Bronchoscopes Market: https://www.zionmarketresearch.com/report/bronchoscopes-market
About Us:
Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research
Follow Us Twitter: https://twitter.com/zion_research
Blog: http://zmrindustryjournal.us | http://zmrresearchnews.us | http://zmrmarketjournal.com | http://zmrindustrynews.us | http://zmrnewsmagazine.com | https://zmrnewsblog.com | http://zmrmarketresearch.com | http://zmrindustryanalysis.com
Contact Us:
Joel John
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com
Blog: http://zmrblog.com